Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-03-13 4:45 pm Purchase | 2023-03-09 | 13G | scPharmaceuticals Inc. SCPH | Millennium Management LLC | 1,722,839 5.100% | 1,722,839 (New Position) | Filing History |
| 2023-02-27 10:06 am Purchase | 2023-02-16 | 13G | scPharmaceuticals Inc. SCPH | Cowen Financial Products LLC | 2,407,562 7.070% | 2,407,562 (New Position) | Filing History |
| 2023-02-15 06:39 am Unchanged | 2022-12-31 | 13G | scPharmaceuticals Inc. SCPH | Orin Hirschman | 2,550,234 7.500% | 0 (Unchanged) | Filing History |
| 2023-02-14 4:04 pm Sale | 2022-12-31 | 13G | scPharmaceuticals Inc. SCPH | 5AM Ventures IV L.P. | 2,734,852 8.000% | -1,096,622 (-28.62%) | Filing History |
| 2023-02-14 1:25 pm Purchase | 2022-12-31 | 13G | scPharmaceuticals Inc. SCPH | Armistice Capital, LLC | 2,148,000 6.310% | 2,148,000 (New Position) | Filing History |
| 2022-11-29 4:27 pm Purchase | 2022-11-25 | 13D | scPharmaceuticals Inc. SCPH | ORBIMED ADVISORS LLC | 5,559,528 16.300% | 762,380 (+15.89%) | Filing History |
| 2022-11-25 06:04 am Purchase | 2022-11-22 | 13G | scPharmaceuticals Inc. SCPH | Orin Hirschman | 2,550,234 7.500% | 2,550,234 (New Position) | Filing History |
| 2022-08-15 5:19 pm Sale | 2022-08-15 | 13G | scPharmaceuticals Inc. SCPH | RA Capital Management, L.P. | 0 0.000% | -2,691,770 (Position Closed) | Filing History |
| 2022-02-18 4:36 pm Sale | 2021-12-31 | 13G | scPharmaceuticals Inc. SCPH | RA Capital Management, L.P. | 2,691,770 9.840% | -4,000,000 (-59.77%) | Filing History |
| 2022-02-14 4:35 pm Sale | 2021-12-31 | 13G | scPharmaceuticals Inc. SCPH | Ikarian Capital, LLC | 901,362 3.300% | -564,785 (-38.52%) | Filing History |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | scPharmaceuticals Inc. SCPH | RA Capital Management, L.P. | 6,691,770 9.840% | 3,172,772 (+90.16%) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | scPharmaceuticals Inc. SCPH | RA Capital Management, L.P. | 3,518,998 12.900% | 271,993 (+8.38%) | Filing History |
| 2021-02-16 06:30 am Purchase | 2020-12-31 | 13G | scPharmaceuticals Inc. SCPH | 5AM Ventures IV L.P. | 3,831,474 14.000% | 578,034 (+17.77%) | Filing History |
| 2021-02-12 4:35 pm Purchase | 2020-12-31 | 13G | scPharmaceuticals Inc. SCPH | Ikarian Capital, LLC | 1,466,147 5.400% | 392,500 (+36.56%) | Filing History |